NMRA
Neumora Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.00
-0.14 ▼ -4.46%
🌙 3월 13일 7:24 PM ET (한국 3/14 08:24)
$3.12
+0.12 ▲ +4.00%
| Index | - | P/E | - | EPS (ttm) | -1.46 | Insider Own | 66.58% | Shs Outstand | 0.16B | Perf Week | -0.66% |
| Market Cap | 0.50B | Forward P/E | - | EPS next Y | 30.51% | Insider Trans | 5.31% | Shs Float | 0.06B | Perf Month | - |
| Enterprise Value | 0.35B | PEG | - | EPS next Q | -0.33 | Inst Own | 24.79% | Short Float | 9.34% | Perf Quarter | 43.54% |
| Income | -0.24B | P/S | - | EPS this Y | 6.95% | Inst Trans | 8.39% | Short Ratio | 3.11 | Perf Half Y | 80.72% |
| Sales | 0.00B | P/B | 3.68 | EPS next 5Y | 12.73% | ROA | -89.11% | Short Interest | 5.22M | Perf YTD | 67.6% |
| Book/sh | 0.82 | P/C | 2.92 | EPS past 3/5Y | 0.69% -586.93% | ROE | -104.35% | 52W High | -17.81% ($3.65) | Perf Year | 114.29% |
| Cash/sh | 1.03 | P/FCF | - | Sales past 3/5Y | - | ROIC | -155.47% | 52W Low | 391% ($0.61) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 20.71% | Gross Margin | - | Volatility(W/M) | 9.47% 8.18% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.26 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 6.85 | EPS Q/Q | 22.86% | Profit Margin | - | RSI (14) | 49.31 | Recom | 1.67 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.85 | Sales Q/Q | - | SMA20 | -8.96% ($3.3) | Beta | 2.56 | Target Price | $9.14 |
| Payout | - | Debt/Eq | 0.15 | Earnings | 11000000 | SMA50 | 15.13% ($2.61) | Rel Volume | 0.39 | Prev Close | $3.14 |
| Employees | 110 | LT Debt/Eq | 0.15 | EPS/Sales Surpr. | -5.11% - | SMA200 | 53.46% ($1.95) | Avg Volume(3M) | 1.68M | Price | $3 |
| IPO | 2023/9/15 | Option/Short | Yes/Yes | Trades | 5738 | Volume | 656,416 | Change | -4.46% |
뉴스 로딩 중...